Literature DB >> 6799018

Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation.

H Link, V Neef, D Niethammer, K Wilms.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6799018     DOI： 10.1007/BF00320957

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  4 in total

Review 1.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

2.  Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle.

Authors:  R Storb; E D Thomas; P L Weiden; C D Buckner; R A Clift; A Fefer; L P Fernando; E R Giblett; B W Goodell; F L Johnson; K G Lerner; P E Neiman; J E Sanders
Journal:  Blood       Date:  1976-12       Impact factor: 22.113

3.  Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results.

Authors:  W Scheef; H O Klein; N Brock; H Burkert; U Günther; H Hoefer-Janker; D Mitrenga; J Schnitker; R Voigtmann
Journal:  Cancer Treat Rep       Date:  1979-03

4.  Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.

Authors:  N Brock; J Stekar; J Pohl; U Niemeyer; G Scheffler
Journal:  Arzneimittelforschung       Date:  1979
  4 in total
  7 in total

1.  Survival and quality of life in 23 patients with severe aplastic anemia treated with bone marrow transplantation (BMT).

Authors:  W Hinterberger; H Gadner; P Höcker; A Hajek-Rosenmayr; W Graninger; G Grabner; B Volc-Platzer; R Hawliczek; K H Kärcher; W Kallinger
Journal:  Blut       Date:  1987-03

2.  Prevention of cyclophosphamide-induced haemorrhagic cystitis by disulfiram.

Authors:  W B Ershler; M P Hacker; R Gamelli
Journal:  Blut       Date:  1982-05

3.  Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide.

Authors:  T Wagner; M Zink; G Schwieder
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiols.

Authors:  N Brock; P Hilgard; J Pohl; K Ormstad; S Orrenius
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

5.  [Bone marrow transplantation in patients with leukemia].

Authors:  K Wilms; H Link; P Meyer; P Ostendorf; K Schüch; H D Waller; P Wernet; D Niethammer; H Dopfer; W Schneider; F Schunter; G Breitling; W Frommhold; G Seeger; A C Voss
Journal:  Klin Wochenschr       Date:  1982-10-15

6.  Mesna does not reduce cisplatin induced nephrotoxicity in the rat.

Authors:  B C Millar; Z H Siddik; J L Millar; S Jinks
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study.

Authors:  J M Hows; A Mehta; L Ward; K Woods; R Perez; M Y Gordon; E C Gordon-Smith
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.